Corrigendum to “Gestational diabetes and progression to type two diabetes mellitus: missed opportunities of follow up and prevention?” [Prim. Care Diabetes 14 (6) (2020) 698–702]

GDM is glucose intolerance which is first diagnosed during pregnancy. In the United Kingdom (UK) and worldwide, prevalence has increased dramatically over the last 10 years with an estimated prevalence of 20% in the UK in 2019 [1]. This is in part due to more inclusive screening policies and stringent diagnostic criteria. In the 2008 Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) study, adverse outcomes were reported at lower levels of hyperglycaemia than previously described [2]. In response the International Association of Diabetes and Pregnancy Study Groups (IADPSG) suggested new diagnostic criteria for GDM [3], which were adopted by the World Health Organisation (WHO) in 2013 [4].

留言 (0)

沒有登入
gif